Company Valuation: MedCap AB

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025 2026 2027 2028
Market Cap 1 4,997 8,899 8,278 8,132 - -
Change - 78.07% -6.99% -1.76% - -
Enterprise Value (EV) 1 4,997 9,176 8,359 8,301 8,081 7,861
Change - 83.61% -8.9% -0.7% -2.65% -2.72%
P/E 29.1x 42.9x - 28.8x 26.7x 23.7x
PBR - 6.95x - 4.56x 3.89x 3.35x
PEG - 2.1x - - 3.5x 1.9x
Capitalization / Revenue - 4.93x 3.93x 3.42x 3.11x 2.85x
EV / Revenue - 5.08x 3.97x 3.49x 3.09x 2.76x
EV / EBITDA - 23.7x 18.3x 13.9x 13.5x 12x
EV / EBIT - 33.7x 27.6x 20.1x 19.7x 17.5x
EV / FCF - 28.8x 26.4x 39.6x 23.7x 20.1x
FCF Yield - 3.47% 3.79% 2.52% 4.22% 4.97%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 11.6 14 - 18.88 20.32 22.91
Distribution rate - - - - - -
Net sales 1 - 1,807 2,108 2,376 2,616 2,850
EBITDA 1 - 387.7 456.3 598 599.5 657.5
EBIT 1 - 272.3 302.9 413.5 410.5 448.5
Net income 1 172.2 207.4 219.8 282 296.5 330
Net Debt 1 - 276.5 81.3 169 -51 -271
Reference price 2 337.50 601.00 549.00 543.00 543.00 543.00
Nbr of stocks (in thousands) 14,807 14,807 15,078 14,976 - -
Announcement Date 31/01/24 31/01/25 05/02/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- 3.49x13.88x - 82Cr
21.58x5.88x12.71x2.02% 18TCr
13.36x3.3x - 2.65% 14TCr
15.81x7.25x - 1.56% 9.93TCr
19.42x6.99x12.46x4.36% 9.33TCr
14.5x9.83x16.85x0.85% 8.25TCr
22.09x11.58x18.97x4.29% 7.47TCr
18.45x10.63x8.19x1.96% 6.75TCr
12.71x4.85x - 2.05% 4.66TCr
Average 17.24x 7.09x 13.84x 2.47% 8.71TCr
Weighted average by Cap. 17.59x 7.02x 13.68x 2.45%

Y-o-Y evolution of P/E

Valuation ratios - P/E - MedCap AB

Historical PBR trend

Valuation ratios - PBR - MedCap AB

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - MedCap AB

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - MedCap AB